drugset / Trial / NCT00937859
Treatment of Patients With Nocturia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate a treatment of nocturia. The hypothesis is that SER120 will decrease the number of nocturic episodes compared to placebo.
Timeline
- Start
- 2009-06
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desmopressin | Peptide | — | Intranasal |
Indications
No indication recorded.